Mansharamani N, Balachandran D, Delaney D, Zibrak J D, Silvestri R C, Koziel H
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Respir Med. 2002 Mar;96(3):178-85. doi: 10.1053/rmed.2001.1247.
Information related to the clinical characteristics and isolated microbes associated with lung abscesses comparing immunocompromised (IC) to non-immunocompromised (non-IC) patients is limited. A retrospective review for 1984-1996 identified 34 consecutive adult cases of lung abscess (representing 0.2% of all cases of pneumonia), including 10 non-IC and 24 IC patients. Comparison of age, gender, tobacco use, pre-existing pulmonary disease or recognized aspiration risk factors were not significantly different between the two groups. Upper lobe involvement accounted for the majority of cases, although multi-lobe involvement was limited to IC patients. There were no differences in the need for surgical intervention, and mortality was very low for both groups. Anaerobes were the most frequent isolates for non-IC patients (30%), whereas aerobes were the most frequent isolate for IC patients (63%). Importantly, certain organisms were exclusively isolated in the IC group and multiple isolates were obtained only from the IC patients.Thus, comparing non-IC to IC patients, clinical characteristics may be similar whereas important differences may exist in the microbiology associated with lung abscess. These findings have important implications for the clinical management of these patient groups, and support a strategy to aggressively identify microbial agents in abscess material.
关于免疫功能低下(IC)患者与非免疫功能低下(非IC)患者肺脓肿的临床特征及分离出的微生物的相关信息有限。一项对1984年至1996年的回顾性研究确定了34例连续的成人肺脓肿病例(占所有肺炎病例的0.2%),其中包括10例非IC患者和24例IC患者。两组在年龄、性别、吸烟情况、既往肺部疾病或公认的误吸危险因素方面的比较无显著差异。尽管多叶受累仅限于IC患者,但上叶受累占大多数病例。两组在手术干预需求方面无差异,且两组死亡率均很低。厌氧菌是非IC患者最常见的分离菌(30%),而需氧菌是IC患者最常见的分离菌(63%)。重要的是,某些微生物仅在IC组中分离出,且仅从IC患者中获得多种分离菌。因此,与非IC患者相比,IC患者的临床特征可能相似,但与肺脓肿相关的微生物学可能存在重要差异。这些发现对这些患者群体的临床管理具有重要意义,并支持在脓肿材料中积极鉴定微生物病原体的策略。